Navigation Links
Parthenon Identifies Emerging Opportunities in Targeted Payload Cancer Therapeutics
Date:9/5/2012

WHITE PLAINS, N.Y., Sept. 5, 2012 /PRNewswire/ -- Parthenon Associates, LLC ("Parthenon" www.parthenonassociates.com), a Financial Consulting firm that provides research and strategic advisory services to Life Sciences, Biotechnology, and Development-Stage Technology companies, has released its report on Targeted Payload Cancer Therapeutics (TPCTs).  The report examines the promise of TPCTs, drugs that combine precision cancer-targeting agents with toxins or radioisotopes, to create powerful and safe treatments for many forms of cancer with a $15 billion market potential.  An in-depth analysis of the dynamic cancer market, cancer treatment, TPCT development, TPCT economic and reimbursement issues, as well as an examination of companies developing these novel drugs are included.

Key Highlights

  • Targeted Payload Cancer Therapeutics recently hit three milestones, rekindling excitement among investors about their marketplace viability, including FDA approval of a TPCT drug and promising results in Phase III trials of two different products. 
  • There is a small but growing pipeline of promising TPCTs in earlier phases of clinical testing.  These products are positioned as first line treatments for indications with significant unmet medical needs.
  • Next generation TPCTs are expected to be priced at a premium based on the cost of alternative treatments, survival benefits, and the economic/reimbursement environment.  Product case studies suggest potential prices ranging from $60,000 to more than $100,000 per treatment.
  • Actinium Pharmaceuticals, Inc. is poised to attain a leadership position in the development TPCTs that combine radioisotope payloads with monoclonal antibody targeting agents.  The company has two lead products already tested in about 300 patients with Phase I and II clinical trials underway:  Ioma
    '/>"/>

SOURCE Parthenon Associates, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
2. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
3. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
4. Synthetic Biology: Emerging Global Markets
5. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
6. All Market Research New Report @ The Worldwide Industry & Regional Market Opportunities With Forecasts to 2016 for Amplifiers and Integrated Microwave Assemblies. (Code name: AIMAs)
7. Its Indiana State Fair Season: New BioCrossroads Report Emphasizes Opportunities in Food and Agriculture Innovation
8. Medtech Expands Nursing Education Opportunities In Florida
9. 2012 US Coagulation Market Outlook: Growth Opportunities and Strategies
10. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
11. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 “This kit ... test to screen from 0 to 150 ppb,” said Mark ... is a significant benefit to plant owners and USDA-GIPSA inspection ... and other commodities. Testing can take place in a matter ... only can the plant test the feed and grain before ...
(Date:8/28/2014)... 28, 2014  Next month, executives from clinical trial marketing ... events beginning with Patient-Centered Clinical Trials 2014 , to ... Boston , September 4-5. Patient recruitment experts Bonnie ... Fleishman will share insights on the benefits of employing ... tactics – from media to mobile apps – can be ...
(Date:8/28/2014)... Washington, USA (PRWEB) August 27, 2014 ... next month for SPIE Laser Damage 2014 ... optical materials for high-power lasers will run 14-17 September. ... society for optics and photonics . , The premier ... for understanding laser damage to optical materials will engage ...
(Date:8/28/2014)... NY (PRWEB) August 28, 2014 Whitehouse ... its long term partnership with PTI Inspection Systems ... clients with state of the art leak testing method ... the art instruments currently available. As part of this ... High Voltage Leak Detection Instrument developed and ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3
... CITY, Calif., Sept. 13 Abaxis, Inc.,(Nasdaq: ... analysis systems, announced today that Clint Severson, CEO ... LLC Sixth Annual San,Francisco Institutional Investor Forum Conference ... Time at The Ritz-Carlton Hotel in San Francisco. ...
... JOSE, Calif., Sept. 13 Micrus,Endovascular Corporation (Nasdaq: ... of Stockholders will be broadcast live over the,Internet on ... (9:00,a.m. Pacific time). Those listening to the meeting via ... ask questions during the,meeting. What: Micrus Endovascular ...
... Exchange Agreement, COPENHAGEN, September 13 Genmab ... asset exchange agreement with,Medarex, Inc. Under the terms ... HuMax-Inflam(TM)/MDX-018, which targets IL-8, and Medarex will,receive full ... and,Medarex will release to each other all previously ...
Cached Biology Technology:Micrus Endovascular to Webcast Fiscal 2007 Annual Meeting of Stockholders 2Genmab Announces Asset Exchange Agreement 2
(Date:8/29/2014)... of the Tibetan plateau -- the largest topographic anomaly ... both its profound effect on climate and its reflection ... GSA Bulletin , Katharine Huntington and colleagues employ a ... modern and fossil snail shells to investigate the uplift ... , Views range widely on the timing of surface ...
(Date:8/28/2014)... of bacterial culprits that may drive inflammatory bowel diseases ... patients, own intestinal immune responses as a guide. , ... Cell . , Trillions of bacteria exist within ... in the development and progression of IBD. Yet it,s ... affect a person,s susceptibility to IBD and its potential ...
(Date:8/28/2014)... E-cigarettes are healthier for your neighbors than traditional ... according to a new study from USC. , ... overall 10-fold decrease in exposure to harmful particles, ... of exposure to some harmful metals in second-hand ... , While tobacco smoke contains high levels of ...
Breaking Biology News(10 mins):Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7Yale study identifies possible bacterial drivers of IBD 2Second-hand e-cig smoke compared to regular cigarette smoke 2
... molecule that not only can sense two common respiratory viruses ... been identified by microbiologists at The University of Texas Health ... Sunday, Aug. 23, by the journal Nature Immunology , ... (RSV) and influenza A (commonly known as flu), both of ...
... of nearly every cell in the body play a central ... found. The discovery in mice shows that the microscopic structures ... skin cancer, depending on the mutation triggering the disease. ... primary cilia activity could offer a new strategy against cancer. ...
... WEST CHESTER, Pa., Aug. 4 ComCam International, Inc. (Pink ... products, solutions and services, today announced that it has been ... and systems integration for a Maritime Domain Awareness and Seaport ... Don Gilbreath stated, "Our two companies have worked informally for ...
Cached Biology News:Microbiologists find defense molecule that senses respiratory viruses 2Some skin cancer may be mediated by primary cilia activity 2Some skin cancer may be mediated by primary cilia activity 3ComCam Selected by ePortation on New Maritime Domain Awareness Project 2